Alemtuzumab in kidney-transplant recipients.
作者信息
Luan Fu L
出版信息
N Engl J Med. 2011 Aug 18;365(7):671; author reply 671-2. doi: 10.1056/NEJMc1106937.
PMID:21848469
Abstract
摘要
相似文献
1
Alemtuzumab in kidney-transplant recipients.阿仑单抗用于肾移植受者。
N Engl J Med. 2011 Aug 18;365(7):671; author reply 671-2. doi: 10.1056/NEJMc1106937.
2
Alemtuzumab in kidney-transplant recipients.阿仑单抗用于肾移植受者。
N Engl J Med. 2011 May 19;364(20):1968-9. doi: 10.1056/NEJMe1103002.
3
Alemtuzumab induction in renal transplantation.阿仑单抗诱导治疗肾移植。
N Engl J Med. 2011 May 19;364(20):1909-19. doi: 10.1056/NEJMoa1009546.
4
Alemtuzumab induction therapy in highly sensitized kidney transplant recipients.阿仑单抗诱导治疗高度致敏的肾移植受者。
Chin Med J (Engl). 2011 Mar;124(5):664-8.
5
Alemtuzumab induction and triple maintenance immunotherapy in kidney transplantation from donors after cardiac death.阿仑单抗诱导及三联维持免疫疗法用于心脏死亡后供体的肾移植
Transpl Int. 2008 Jul;21(7):625-36. doi: 10.1111/j.1432-2277.2008.00642.x. Epub 2008 Apr 4.
6
Alemtuzumab versus interleukin-2 receptor antibodies induction in living donor kidney transplantation.阿仑单抗与白细胞介素-2 受体抗体诱导在活体供肾移植中的应用。
Transplantation. 2009 Oct 15;88(7):904-10. doi: 10.1097/TP.0b013e3181b724a5.
7
Effect of alemtuzumab or basiliximab induction therapy on graft function and survival of kidneys from donors after cardiac death.阿仑单抗或巴利昔单抗诱导治疗对心脏死亡后供者肾脏移植功能及存活的影响。
Transpl Int. 2009 Oct;22(10):1024-7. doi: 10.1111/j.1432-2277.2009.00910.x. Epub 2009 Jul 13.
8
A randomized trial of alemtuzumab versus antithymocyte globulin induction in renal and pancreas transplantation.阿仑单抗与抗胸腺细胞球蛋白在肾和胰腺移植中诱导治疗的随机试验。
Transplantation. 2009 Sep 27;88(6):810-9. doi: 10.1097/TP.0b013e3181b4acfb.
9
Alemtuzumab induction therapy in kidney transplantation.
Lancet. 2014 Nov 8;384(9955):1649-51. doi: 10.1016/S0140-6736(14)61174-0. Epub 2014 Jul 28.
10
Alemtuzumab induction therapy in kidney transplantation.
Lancet. 2015 Feb 28;385(9970):770-1. doi: 10.1016/S0140-6736(15)60431-7.
Zotero 插件